[Fixed-Drug Combination Amlodipine, Indapamide and Perindopril: New Horizons of Antihypertensive Therapy]

Area of Science:

• Cardiology
• Pharmacology

Background:

• Arterial hypertension is highly prevalent, with suboptimal blood pressure (BP) control necessitating advanced therapeutic strategies.
• Individualized pathophysiologic mechanisms in hypertension vary throughout a patient's life, complicating treatment.
• Combined antihypertensive therapy targets diverse mechanisms, enhancing BP reduction and mitigating side effects.

Purpose of the Study:

• To evaluate the effectiveness of a novel fixed-dose combination of amlodipine, indapamide, and perindopril in managing arterial hypertension.
• To assess the benefits of fixed-dose combinations in improving treatment adherence and therapeutic outcomes.

Main Methods:

• Utilizing a fixed-dose combination of amlodipine, indapamide, and perindopril.
• Leveraging evidence from international trials confirming the antihypertensive efficacy of individual components.

Main Results:

• The combination therapy demonstrated significant BP reduction.
• Improved patient adherence to treatment regimens was observed.
• Reduced heterogeneity in treatment response was noted.

Conclusions:

• The fixed-dose combination of amlodipine, indapamide, and perindopril effectively addresses modern antihypertensive therapy principles.
• This combination offers a promising approach for enhanced BP management and improved patient outcomes.